Page last updated: 2024-10-28

glipizide and Diabetic Angiopathies

glipizide has been researched along with Diabetic Angiopathies in 15 studies

Glipizide: An oral hypoglycemic agent which is rapidly absorbed and completely metabolized.
glipizide : An N-sulfonylurea that is glyburide in which the (5-chloro-2-methoxybenzoyl group is replaced by a (5-methylpyrazin-2-yl)carbonyl group. An oral hypoglycemic agent, it is used in the treatment of type 2 diabetes mellitus.

Diabetic Angiopathies: VASCULAR DISEASES that are associated with DIABETES MELLITUS.

Research Excerpts

Excerpt	Relevance	Reference
"To determine (1) the medium-term effect of rosiglitazone and glipizide on intra-stent neointima hyperplasia, (2) restenosis pattern as assessed by intra-vascular ultrasound (IVUS) and quantitative coronary angiography (QCA) in patients with T2DM and coronary artery disease."	5.16	Evaluation of in-stent restenosis in the APPROACH trial (Assessment on the Prevention of Progression by Rosiglitazone On Atherosclerosis in diabetes patients with Cardiovascular History). ( Brugaletta, S; García-García, HM; Garg, S; Huang, C; Kolatkar, NS; Kravitz, BG; Miller, DM; Morocutti, G; Nesto, RW; Ratner, RE; Serruys, PW, 2012)
"APPROACH has fully enrolled a high-risk patient population and will compare the glucose-independent effects of rosiglitazone and glipizide on the progression of coronary atherosclerosis, as well as provide additional data on the cardiovascular safety of rosiglitazone in patients with type 2 diabetes and coronary artery disease."	5.13	Assessment on the Prevention of Progression by Rosiglitazone on Atherosclerosis in diabetes patients with Cardiovascular History (APPROACH): study design and baseline characteristics. ( Cannon, CP; Fitzgerald, PJ; Gerstein, HC; Kolatkar, NS; Kravitz, BG; Nesto, RW; Ratner, RE; Serruys, PW; Van Es, GA; Zalewski, A, 2008)
"3867 newly diagnosed patients with type 2 diabetes, median age 54 years (IQR 48-60 years), who after 3 months' diet treatment had a mean of two fasting plasma glucose (FPG) concentrations of 6."	2.69	Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. ( , 1998)
"Intense stepped insulin therapy in NIDDM patients who have failed glycemic control on pharmacological therapy is effective in maintaining near-normal glycemic control for > 2 years without excessive severe hypoglycemia, weight gain, hypertension, or dyslipidemia."	2.68	Veterans Affairs Cooperative Study on glycemic control and complications in type II diabetes (VA CSDM). Results of the feasibility trial. Veterans Affairs Cooperative Study in Type II Diabetes. ( Abraira, C; Colwell, JA; Comstock, JP; Emanuele, NV; Henderson, W; Lee, HS; Levin, SR; Nagel, NJ; Nuttall, FQ; Sawin, CT, 1995)
"Glimepiride was associated with the best clinical outcome, showing the lowest mortality and lowest cardiovascular event risk of the five insulin secretagogues."	1.51	Comparison of mortality and cardiovascular event risk associated with various insulin secretagogues: A nationwide real-world analysis. ( Huang, HK; Yeh, JI, 2019)
"Initiating treatment of type 2 diabetes with glibenclamide or glipizide is associated with increased risk of CAD in comparison to gliclazide or glimepiride."	1.35	Risk of coronary artery disease associated with initial sulphonylurea treatment of patients with type 2 diabetes: a matched case-control study. ( Mogensen, CE; Sadikot, SM, 2008)
"Glipizide-treated mice improved their OGTT."	1.28	Diabetic microangiopathy in KK mice. VI. Effect of glycemic control on renal glycoprotein metabolism and established glomerulosclerosis. ( Camerini-Davalos, RA; Khan, MY; Reddi, AS; Reddy, PR; Velasco, CA, 1990)

Research

Studies (15)

Timeframe	Studies, this research(%)	All Research%
pre-1990	4 (26.67)	18.7374
1990's	5 (33.33)	18.2507
2000's	2 (13.33)	29.6817
2010's	4 (26.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Leonard, CE	1
Brensinger, CM	1
Aquilante, CL	1
Bilker, WB	1
Boudreau, DM	1
Deo, R	1
Flory, JH	1
Gagne, JJ	1
Mangaali, MJ	1
Hennessy, S	1
Huang, HK	1
Yeh, JI	1
Zhang, Y	1
Hu, C	1
Hong, J	1
Zeng, J	1
Lai, S	1
Lv, A	1
Su, Q	1
Dong, Y	1
Zhou, Z	1
Tang, W	1
Zhao, J	1
Cui, L	1
Zou, D	1
Wang, D	1
Li, H	1
Liu, C	1
Wu, G	1
Shen, J	1
Zhu, D	1
Wang, W	1
Shen, W	1
Ning, G	1
Xu, G	1
Sadikot, SM	1
Mogensen, CE	1
Ratner, RE	2
Cannon, CP	1
Gerstein, HC	1
Nesto, RW	2
Serruys, PW	2
Van Es, GA	1
Kolatkar, NS	2
Kravitz, BG	2
Zalewski, A	1
Fitzgerald, PJ	1
García-García, HM	1
Garg, S	1
Brugaletta, S	1
Morocutti, G	1
Miller, DM	1
Huang, C	1
Camerini-Davalos, RA	4
Velasco, C	1
Glasser, M	3
Bloodworth, JM	3
Abraira, C	2
Colwell, JA	1
Nuttall, FQ	1
Sawin, CT	1
Nagel, NJ	1
Comstock, JP	1
Emanuele, NV	1
Levin, SR	1
Henderson, W	2
Lee, HS	1
O'Brien, RC	1
Luo, M	1
Emanuele, N	1
Colwell, J	1
Comstock, J	1
Levin, S	1
Nuttall, F	1
Sawin, C	1
Reddi, AS	2
Velasco, CA	3
Reddy, PR	1
Khan, MY	1

Clinical Trials (42)

Trial Overview

Trial	Phase	Enrollment	Study Type	Start Date	Status
A Phase III, 18 Month, Multicenter, Randomized, Double-Blind, Active-Controlled Clinical Trial to Compare Rosiglitazone Versus Glipizide on the Progression of Atherosclerosis in Subjects With Type 2 Diabetes Mellitus and Cardiovascular Disease (APPROACH)[NCT00116831]	Phase 3	672 participants (Actual)	Interventional	2005-01-31	Completed
Glycemic Control Assessed by Continuous Glucose Monitoring in Hemodialyzed Patients With Diabetes Mellitus Treated Via the Basal-Bolus Detemir-Aspart Insulin Regimen: A Pilot Study[NCT01828970]	Phase 4	38 participants (Actual)	Interventional	2010-01-31	Completed
Effectiveness and Cost-effectiveness Analysis of a Telemonitoring Program on Lifestyle for People With Type 2 Diabetes at Home. Study Based on a Health Network in Diabetology.[NCT01955031]		282 participants (Actual)	Interventional	2013-11-30	Completed
The Study to Investigate the Contribution of Basal and Post-prandial Blood Glucose to Overall Glycaemia in Subjects With Normal Glycaemic Metabolism and Type 2 Diabetes[NCT02648685]		337 participants (Actual)	Observational	2015-11-30	Completed
Phase 1 Study To Determine the Effects of Short Term Near-infrared Light (NIR) Therapy on Anatomic and Functional Abnormalities of Diabetic Macular Edema, and Assess Safety of Short Term Near-infrared Light Therapy in Eyes With Diabetic Macular Edema.[NCT00846092]	Phase 1	4 participants (Actual)	Interventional	2007-11-30	Completed
Carbohydrate Days as Simple and Efficient Therapy for Patients With Type 2 Diabetes Mellitus and Insulin Resistance: Oatmeal and Insulin Resistance (OMA-IR).[NCT00401453]	Phase 3	15 participants (Anticipated)	Interventional	2007-01-31	Completed
Prospective, Parallel Goups Study, Aimed to Evaluating Possible Benefits of the Treatment of New Generation Hypoglycaemic Drugs Compared to Sulphonylureas for the Tratment of Type 2 Diabetes Mellitus[NCT04272359]		138 participants (Anticipated)	Observational [Patient Registry]	2019-05-06	Recruiting
Time in Glucose Hospital Target (TIGHT) - A Randomized Clinical Trial to Evaluate the Use of CGM to Achieve a Mean Glucose Target of 90 to 130 mg/dL Without Hypoglycemia in Hospitalized Adults With Type 2 Diabetes[NCT05135676]		150 participants (Anticipated)	Interventional	2022-05-10	Recruiting
A Multicentre Observational Study to Investigate the Improvement in Glucose FLuctuation of Sufficient Acarbose Therapy on Type 2 Diabetes Patient With High Blood Glucose Fluctuation[NCT03805191]		900 participants (Anticipated)	Observational	2019-01-01	Recruiting
The Effectiveness of Nurse Practitioner Led Group Visits in Improving Compliance With Diabetic Preventative Services and Modifying Vascular Risk[NCT00204282]		150 participants	Interventional	2003-08-31	Completed
Effects and Safety of GUideline Algorithm Based Intervention on CaRdiovascular and Renal Outcomes in Elderly Diabetic Patients With High Cardiovascular Risk in the Community- A Cluster Randomized Controlled Trial (GUARD-Community Study)[NCT05349955]		5,600 participants (Anticipated)	Interventional	2022-11-21	Recruiting
Comparative Effects of Empagliflozin Versus Glimepiride After 26-weeks of Treatment Add on Metformin on Myocardial Metabolic Rate of Glucose Estimated Through 18FDG-PET in Patients With Type 2 Diabetes[NCT04183868]	Phase 4	26 participants (Actual)	Interventional	2016-04-30	Completed
Randomized Trial to Assess the Effect of Using Alternate Site Blood Glucose Testing Versus Finger-Tip Testing on Long-Term Glycemic Control.[NCT00207207]	Phase 1	174 participants	Interventional	2003-07-31	Completed
GLUCOSE : Glucose Lowering by Usual Care Or Specialized Endocrinology Team[NCT00248352]		212 participants (Anticipated)	Interventional	2005-02-28	Completed
The Impact of Liraglutide on Glucose Tolerance and the Risk of Type 2 Diabetes in Women With Previous Gestational Diabetes Mellitus[NCT01795248]	Phase 4	105 participants (Actual)	Interventional	2012-07-31	Completed
"The Effect of Rehabilitation of Type 2 Diabetes Mellitus Versus Standard Outpatient Care. A Randomized Controlled Trial."[NCT00284609]		180 participants (Anticipated)	Interventional	2006-08-31	Completed
Effect of Different Doses of Salacinol Extract on Glycemic and Insulinemic Response in Patients With Type 2 Diabetes[NCT00306072]	Phase 1/Phase 2	82 participants	Interventional	2005-06-30	Completed
Effectiveness and Tolerability of Novel, Initial Triple Combination Therapy With Xigduo (Dapagliflozin Plus Metformin) and Saxagliptin vs. Conventional Stepwise add-on Therapy in Drug-naïve Patients With Type 2 Diabetes[NCT02946632]	Phase 3	104 participants (Anticipated)	Interventional	2016-12-31	Not yet recruiting
PRecisiOn MEdicine to Target Frailty of Endocrine-metabolic Origin[NCT04856683]		1,100 participants (Anticipated)	Observational	2020-08-10	Recruiting
A 16-wk, Uni-center, Randomized, Double-blind, Parallel, Phase 3b Trial to Evaluate Efficacy of Saxagliptin + Dapagliflozin vs.Dapagliflozin With Regard to EGP in T2DM With Insufficient Glycemic Control on Metformin+/-Sulfonylurea Therapy[NCT02613897]		56 participants (Actual)	Interventional	2016-01-31	Completed
Efficacy of a Virtual Care Clinic in the Management of Diabetes Mellitus[NCT02681185]		11 participants (Actual)	Interventional	2018-03-01	Terminated (stopped due to enrollment not satisfied)
Investigating if an Internet-Based Glucose Monitoring System is as Effective as Medication at Reducing HbA1c Levels in Type 2 Diabetes Mellitus[NCT02185755]		60 participants (Actual)	Interventional	2014-08-31	Completed
The Effect of a Checklist on the Quality of Education During Insulin Initiation by Trained Medical Students: a Randomized Controlled Trial[NCT02313805]		100 participants (Anticipated)	Interventional	2014-07-31	Recruiting
Intravitreal Injections of Ziv-aflibercept for Macular Diseases: Diabetic Macular Edema, Wet AMD and Macular Edema Secondary to Vein Occlusons[NCT02556723]		60 participants (Anticipated)	Interventional	2014-09-30	Completed
Differences in Hemoglobin Glycation Rate in Diabete Mellitus Patients[NCT01213277]		25 participants (Anticipated)	Interventional	2010-10-31	Suspended (stopped due to a pilot study of 7 patients did not reveal a temperature dependent difference in glycation rates)
HbA1c as an Early Serologic Marker for the Hemodynamic Progression of Stage A Heart[NCT04450576]		200 participants (Anticipated)	Observational	2019-12-20	Active, not recruiting
From Clinic to Community: Using Peer Support as a Transition Model for Improving Long-term Diabetes-related Health Outcomes[NCT02804620]	Early Phase 1	228 participants (Anticipated)	Interventional	2014-10-31	Recruiting
Research on Human Insulin rDNA (Insuget) Safety and Efficacy in Patients With Type 2 Diabetes Mellitus[NCT05161741]	Phase 4	238 participants (Actual)	Interventional	2021-01-01	Completed
Does Glycated Hemoglobin Variability in Type 2 Diabetes Differ Depending on the Diabetes Treatment Threshold Used in the Qatari Population: Implication on Diabetes Complication Risk?[NCT02879409]		150 participants (Anticipated)	Interventional	2016-11-30	Active, not recruiting
Effect of Internet Therapeutic Intervention on A1C Levels in Type 2 Diabetes Mellitus on Monotherapy[NCT01044368]		50 participants (Anticipated)	Interventional	2010-01-31	Suspended (stopped due to To focus on a similar study NCT01175408 prior to recruiting participants.)
STAMPEDE: Surgical Therapy And Medications Potentially Eradicate Diabetes Efficiently[NCT00432809]		150 participants (Actual)	Interventional	2007-02-28	Completed
Variability of Glucose Assessed in a Randomized Trial Comparing the Initiation of A Treatment Approach With Biosimilar Basal Insulin Analog Or a Titratable iGlarLixi combinatioN in Type 2 Diabetes Among South Asian Subjects (VARIATION 2 SA Trial)[NCT03819790]	Phase 4	119 participants (Actual)	Interventional	2018-10-02	Completed
A Multi-centre, Open-labeled, Randomized, Parallel Study on Liver Fat Content and Visceral Fat Mass in Overweight and Obese Type 2 Diabetes Patients After 26 Weeks Treatment With Insulin Detemir Once Daily Versus Insulin NPH Once Daily[NCT01310452]		50 participants (Anticipated)	Interventional	2011-01-31	Active, not recruiting
The Risk Factors of Cardiovascular Disease in Elderly Diabetic Patients: A Prospective Cohort Study[NCT04544527]		10,000 participants (Anticipated)	Observational	2020-09-01	Recruiting
Protocol: Comparing the Effect of Using an Internet-Based Glucose Monitoring System Versus the Continuous Glucose Monitoring System on HbA1c Levels in Type 2 DM[NCT01162694]		50 participants (Anticipated)	Interventional	2010-07-31	Suspended (stopped due to Study was expanded and included in another study.)
Effect of Internet Therapeutic Intervention on A1C Levels in Type 2 Diabetes Mellitus on Combination Oral Therapy[NCT01060241]		50 participants (Anticipated)	Interventional	2010-02-28	Suspended (stopped due to Other projects warranted more attention)
Blood Monitoring and Data Acquisition and Utilization in Patients With Type 2 Diabetes Treated With Insulin[NCT01175408]		100 participants (Actual)	Interventional	2010-09-30	Completed
Addition of Liraglutide to Overweight Patients With Type 2 Diabetes Treated With Multiple Daily Insulin Injections (MDI) With Inadequate Glycaemic Control[NCT02113332]	Phase 2	124 participants (Actual)	Interventional	2013-01-31	Completed
SEMAGLUTIDE VERSUS GLP-1 RECEPTOR AGONISTS. EFFECTIVENESS , SAFETY AND QUALITY OF LIFE IN PATIENTS WITH DIABETES MELLITUS 2. OBSERVATIONAL, PROSPECTIVE AND MULTICENTER STUDY. SEVERAL STUDY.[NCT05136287]		140 participants (Actual)	Observational	2022-02-01	Active, not recruiting
A Prospective Consortium Evaluating the Long-term Follow-up of Patients With Type 2 Diabetes Enrolled In a Randomized Controlled Trial Comparing Bariatric Surgery Versus Medical Management[NCT02328599]		302 participants (Anticipated)	Observational	2018-04-10	Enrolling by invitation
Health Benefits of Aerobic and Resistance Training in Individuals With Type 2 Diabetes[NCT00458133]		262 participants (Actual)	Interventional	2007-04-30	Completed
Magnetic Resonance Assessment of Victoza Efficacy in the Regression of Cardiovascular Dysfunction In Type 2 Diabetes Mellitus[NCT01761318]	Phase 4	50 participants (Actual)	Interventional	2013-11-30	Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

Change From Baseline to Month 18 in LDL-c Peak Particle Density Measured by LDL Relative Flotation

From repeated measures analysis model: Change = baseline + visit + sex + region + treatment + prior OAD + cardiac procedure + treatment x visit. (NCT00116831)
Timeframe: Baseline to Month 18

Intervention	Ratio (Mean)
Glipizide (GLP) 5 mg	0.0040
Rosiglitazone (RSG) 4 mg	0.0204

Change From Baseline to Month 18 in LDL-c/HDL-c Ratio

From repeated measures analysis model: Change = baseline + visit + sex + region + treatment + prior OAD + cardiac procedure + treatment x visit. (NCT00116831)
Timeframe: Baseline to Month 18

Intervention	ratio (Mean)
Glipizide (GLP) 5 mg	-0.365
Rosiglitazone (RSG) 4 mg	-0.226

Change From Baseline to Month 18 in Total Cholesterol/HDL-c Ratio

From repeated measures analysis model: Change = baseline + visit + sex + region + treatment + prior OAD + cardiac procedure + treatment x visit. (NCT00116831)
Timeframe: Baseline to Month 18

Intervention	ratio (Mean)
Glipizide (GLP) 5 mg	-0.495
Rosiglitazone (RSG) 4 mg	-0.377

Model Adjusted Change From Baseline in Atheroma Area to Month 18

IVUS-derived endpoints measured within the same segment (in non-intervened coronary arteries) from Baseline to Month 18. Model Adjusted Change (MAC) = Baseline + Region + Sex + Treatment + Cardiac Procedure + Prior OAD Medication. (NCT00116831)
Timeframe: Baseline to Month 18

Intervention	millimeters square (mm2) (Mean)
Glipizide (GLP) 5 mg	0.03
Rosiglitazone (RSG) 4 mg	-0.10

Model Adjusted Change From Baseline in Atheroma Volume to Month 18

Intervention	millimeters cubed (mm3) (Mean)
Glipizide (GLP) 5 mg	0.98
Rosiglitazone (RSG) 4 mg	-3.60

Model Adjusted Change From Baseline in Lumen Area to Month 18

Intervention	millimeters square (mm2) (Mean)
Glipizide (GLP) 5 mg	-0.14
Rosiglitazone (RSG) 4 mg	-0.11

Model Adjusted Change From Baseline in Lumen Volume to Month 18

Intervention	millimeters cubed (mm3) (Mean)
Glipizide (GLP) 5 mg	-4.91
Rosiglitazone (RSG) 4 mg	-4.59

Model Adjusted Change From Baseline in Normalized Atheroma Volume

IVUS-derived endpoints measured within the same segment (in non-intervened coronary arteries) from Baseline to Month 18. Normalized atheroma volume is defined as mean atheroma area x median segment length in cohort. Model Adjusted Change = Baseline + Region + Sex + Treatment + Cardiac Procedure + Prior OAD Medication. (NCT00116831)
Timeframe: Baseline to Month 18

Intervention	millimeters cubed (mm3) (Mean)
Glipizide (GLP) 5 mg	1.20
Rosiglitazone (RSG) 4 mg	-3.92

Model Adjusted Change From Baseline in Percent Atheroma Volume (PAV) to Month 18

Model Adjusted Change (MAC) = Baseline + Region + Sex + Treatment + Cardiac Procedure + Prior Oral Anti-Hyperglycemic Diabetic Medications(s) (OAD). (NCT00116831)
Timeframe: Baseline to Month 18

Intervention	percent (absolute change) (Mean)
Glipizide (GLP) 5 mg	0.43
Rosiglitazone (RSG) 4 mg	-0.21

Model Adjusted Change From Baseline in Vessel Area to Month 18

Intervention	millimeters square (mm2) (Mean)
Glipizide (GLP) 5 mg	-0.10
Rosiglitazone (RSG) 4 mg	-0.21

Model Adjusted Change From Baseline in Vessel Volume to Month 18

Intervention	millimeters cubed (mm3) (Mean)
Glipizide (GLP) 5 mg	-4.56
Rosiglitazone (RSG) 4 mg	-8.13

Model Adjusted Change in Atheroma Area Within the 10 mm of the Non-intervened Vessel Segment With the Greatest Atheroma Volume at Baseline

IVUS-derived endpoints measured within the same 10 mm segment of non-intervened coronary arteries with the greatest degree of atheroma volume at Baseline, from Baseline to Month 18, including the nominal change in atheroma volume and atheroma area. Model Adjusted Change = Baseline + Region + Sex + Treatment + Cardiac Procedure + Prior OAD Medication. (NCT00116831)
Timeframe: Baseline to Month 18

Intervention	millimeters squared (mm2) (Mean)
Glipizide (GLP) 5 mg	-0.39
Rosiglitazone (RSG) 4 mg	-0.50

Model Adjusted Change in Atheroma Volume Within the 10 mm of the Non-intervened Vessel Segment With the Greatest Atheroma Volume at Baseline

Intervention	millimeters cubed (mm3) (Mean)
Glipizide (GLP) 5 mg	-3.56
Rosiglitazone (RSG) 4 mg	-5.28

Model Adjusted Change in Fasting Plasma Glucose (FPG) From Baseline to Month 18

From repeated measures analysis model: Change = Baseline + visit + sex + region + treatment + prior OAD + cardiac procedure + treatment x visit. (NCT00116831)
Timeframe: Baseline to Month 18

Intervention	millimole/Liter (mmol/L) (Mean)
Glipizide (GLP) 5 mg	-0.46
Rosiglitazone (RSG) 4 mg	-1.34

Model Adjusted Change in Glycated Hemoglobin (HbA1c) From Baseline to Month 18

From repeated measures analysis model: Change = Baseline + visit + sex + region + treatment + prior Oral Anti-Hyperglycemic Diabetic Medications(s) (OAD) + cardiac procedure + treatment x visit. (NCT00116831)
Timeframe: Baseline to Month 18

Intervention	Percentage (Mean)
Glipizide (GLP) 5 mg	-0.20
Rosiglitazone (RSG) 4 mg	-0.30

Number of Participants With the Indicated Treatment Emergent Major Cardiovascular Events (MACE) for All-cause Death, Non-fatal MI, Non-fatal Stroke, Coronary Revascularization, or Hospitalization for Recurrent Myocardial Ischemia (MACE Composite 1)

This was 1 of 2 MACE composite endpoints and was a secondary efficacy endpoint. (NCT00116831)
Timeframe: Baseline to Month 21

Intervention	Participants (Number)
Glipizide (GLP) 5 mg	38
Rosiglitazone (RSG) 4 mg	39

Number of Participants With the Indicated Treatment Emergent Major Cardiovascular Events (MACE) for Cardiovascular Death, Nonfatal MI, or Nonfatal Stroke (MACE Composite 2)

This was 1 of 2 MACE composite endpoints and was a secondary efficacy endpoint. (NCT00116831)
Timeframe: Baseline to Month 21

Intervention	Participants (Number)
Glipizide (GLP) 5 mg	10
Rosiglitazone (RSG) 4 mg	14

Change From Baseline in Atheroma, Vessel, and Lumen Area to Month 18

IVUS-derived endpoints measured within the same segment (in non-intervened coronary arteries) from Baseline to Month 18 (NCT00116831)
Timeframe: Baseline to Month 18

Intervention	millimeters squared (mm2) (Mean)
	Atheroma Area, Baseline	Atheroma Area, Month 18	Change from Baseline in Atheroma Area	Vessel Area, Baseline	Vessel Area, Month 18	Change from Baseline in Vessel Area	Lumen Area, Baseline	Lumen Area, Month 18	Change from Baseline in Lumen Area
Glipizide (GLP) 5 mg	5.918	5.928	0.010	14.364	14.261	-0.102	8.447	8.335	-0.113
Rosiglitazone (RSG) 4 mg	5.748	5.634	-0.114	14.166	13.977	-0.189	8.419	8.344	-0.075

Change From Baseline in Atheroma, Vessel, and Lumen Volume to Month 18

IVUS-derived endpoints measured within the same segment (in non-intervened coronary arteries) from Baseline to Month 18 (NCT00116831)
Timeframe: Baseline to Month 18

Intervention	millimeters cubed (mm3) (Mean)
	Atheroma Volume, Baseline	Atheroma Volume, Month 18	Change from Baseline in Atheroma Volume	Vessel Volume, Baseline	Vessel Volume, Month 18	Change from Baseline in Vessel Volume	Lumen Volume, Baseline	Lumen Volume, Month 18	Change from Baseline in Lumen Volume
Glipizide (GLP) 5 mg	249.747	249.625	-0.123	609.378	603.088	-6.290	359.726	353.513	-6.213
Rosiglitazone (RSG) 4 mg	222.431	218.576	-3.854	555.062	547.186	-7.876	332.688	328.676	-4.012

Change From Baseline in Normalized Atheroma Volume

Intervention	millimeters cubed (mm3) (Mean)
	Baseline	Month 18	Change from Baseline
Glipizide (GLP) 5 mg	232.772	233.153	0.381
Rosiglitazone (RSG) 4 mg	226.075	221.599	-4.476

Change From Baseline in Percent Atheroma Volume (PAV) to Month 18

The primary efficacy endpoint was change in PAV (defined as total atheroma volume divided by total vessel volume x 100) within a 40 mm segment in non-intervened coronary arteries from Baseline to Month 18, based upon Intravascular Ultrasound (IVUS) assessment. (NCT00116831)
Timeframe: Baseline to Month 18

Intervention	percent (absolute change) (Mean)
	Baseline	Month 18	Change from Baseline
Glipizide (GLP) 5 mg	40.593	41.013	0.420
Rosiglitazone (RSG) 4 mg	40.422	40.182	-0.240

Change in Atheroma Area Within the 10 mm of the Non-intervened Vessel Segment With the Greatest Atheroma Volume at Baseline

Intervention	millimeters squared (mm2) (Mean)
	Baseline	Month 18	Change from Baseline
Glipizide (GLP) 5 mg	7.569	7.185	-0.384
Rosiglitazone (RSG) 4 mg	7.093	6.625	-0.468

Change in Atheroma Volume Within the 10 mm of the Non-intervened Vessel Segment With the Greatest Atheroma Volume at Baseline

Intervention	millimeters cubed (mm3) (Mean)
	Baseline	Month 18	Change from Baseline
Glipizide (GLP) 5 mg	75.649	72.225	-3.424
Rosiglitazone (RSG) 4 mg	70.961	66.020	-4.941

Model Adjusted Percent Change in Brain Natriuretic Peptide (BNP) From Baseline to Month 18

It was measured as ratio to baseline as percentage change based on log-transformed data : 100 x (exp(Mean change on log scale) - 1). Model Adjusted change based on ANCOVA: Log(value) - log(Baseline) = log(Baseline) + sex + region + treatment + prior OAD + cardiac procedure. (NCT00116831)
Timeframe: Baseline to Month 18

Intervention	percent change (Number)
	Adjusted Geometric Mean + Standard Error	Adjusted Geometric Mean	Adjusted Geometric Mean - Standard Error
Glipizide (GLP) 5 mg	-4.865	-11.388	-17.465
Rosiglitazone (RSG) 4 mg	24.576	15.720	7.499

Number of Other Cardiovascular Events

This was one of the secondary endpoints of the study. (NCT00116831)
Timeframe: Baseline to Month 21

Intervention	Number of events (Number)
	All-cause death	Cardiovascular death	Non-fatal myocardial infarction	Non-fatal stroke	Coronary revascularization	Hospitalization for recurrent myocardial ischemia	Non-MACE congestive heart failure
Glipizide (GLP) 5 mg	7	3	6	1	27	7	3
Rosiglitazone (RSG) 4 mg	8	4	7	5	26	11	8

Percent Change From Baseline to Month 18 in Apoprotein B (apoB)

Repeated measures analysis model: Log(value) - log (Baseline) = log(Baseline) + visit + sex + region + treatment + prior OAD + cardiac procedure + treatment x visit. (NCT00116831)
Timeframe: Baseline to Month 18

Intervention	percent change (Number)
	Adjusted Geometric Mean + Standard Error	Adjusted Geometric Mean	Adjusted Geometric Mean - Standard Error
Glipizide (GLP) 5 mg	-6.588	-8.320	-10.021
Rosiglitazone (RSG) 4 mg	-6.967	-8.744	-10.488

Percent Change From Baseline to Month 18 in Free Fatty Acids (FFA)

Intervention	percent change (Number)
	Adjusted Geometric Mean + Standard Error	Adjusted Geometric Mean	Adjusted Geometric Mean - Standard Error
Glipizide (GLP) 5 mg	32.909	27.303	21.943
Rosiglitazone (RSG) 4 mg	13.835	8.880	4.142

Percent Change From Baseline to Month 18 in HDL-2

Intervention	percent change (Number)
	Adjusted Geometric Mean + Standard Error	Adjusted Geometric Mean	Adjusted Geometric Mean - Standard Error
Glipizide (GLP) 5 mg	2.065	-0.783	-3.550
Rosiglitazone (RSG) 4 mg	18.241	14.821	11.507

Percent Change From Baseline to Month 18 in HDL-3

Intervention	percent change (Number)
	Adjusted Geometric Mean + Standard Error	Adjusted Geometric Mean	Adjusted Geometric Mean - Standard Error
Glipizide (GLP) 5 mg	10.683	9.074	7.490
Rosiglitazone (RSG) 4 mg	15.165	13.440	11.732

Percent Change From Baseline to Month 18 in High Density Lipoprotein Cholesterol (HDL-c)

Intervention	percent change (Number)
	Adjusted Geometric Mean + Standard Error	Adjusted Geometric Mean	Adjusted Geometric Mean - Standard Error
Glipizide (GLP) 5 mg	7.208	5.710	4.233
Rosiglitazone (RSG) 4 mg	15.104	13.440	11.808

Percent Change From Baseline to Month 18 in Low Density Lipoprotein Cholesterol (LDL-c)

Intervention	percent change (Number)
	Adjusted Geometric Mean + Standard Error	Adjusted Geometric Mean	Adjusted Geometric Mean - Standard Error
Glipizide (GLP) 5 mg	-8.955	-11.600	-14.172
Rosiglitazone (RSG) 4 mg	1.795	-1.237	-4.180

Percent Change From Baseline to Month 18 in Total Cholesterol (TC)

Intervention	percent change (Number)
	Adjusted Geometric Mean + Standard Error	Adjusted Geometric Mean	Adjusted Geometric Mean - Standard Error
Glipizide (GLP) 5 mg	-4.205	-5.644	-7.062
Rosiglitazone (RSG) 4 mg	3.151	1.567	0.007

Percent Change From Baseline to Month 18 in Triglycerides (TG)

Intervention	percent change (Number)
	Adjusted Geometric Mean + Standard Error	Adjusted Geometric Mean	Adjusted Geometric Mean - Standard Error
Glipizide (GLP) 5 mg	-7.415	-10.309	-13.110
Rosiglitazone (RSG) 4 mg	-13.601	-16.381	-19.067

Percent Change in Brain Natriuretic Peptide (BNP) From Baseline to Month 18

It was measured as ratio to baseline as percentage change based on log-transformed data : 100 x (exp(Mean change on log scale) - 1)It was measured as ratio to baseline as percentage change based on log-transformed data : 100 x (exp(Mean change on log scale) - 1). Ratio to baseline as %change mean (%) was used as the estimation parameter for both groups. (NCT00116831)
Timeframe: Baseline to Month 18

Intervention	percent change (Number)
	Mean + Standard Error	Mean	Mean - Standard Error
Glipizide (GLP) 5 mg	1.141	-6.608	-13.764
Rosiglitazone (RSG) 4 mg	30.189	20.582	11.683

Repeated Measures Analysis of Percent Change in hsCRP From Baseline to Month 18

Changes in cardiovascular biomarkers from Baseline to Month 18, such as high sensitivity C-reactive protein (hsCRP) . Repeated measures analysis model: Log(value) - log(baseline) = log(baseline) + visit + sex + region + treatment + prior OAD + cardiac procedure + treatment x visit. (NCT00116831)
Timeframe: Baseline to Month 18

Intervention	percent change (Number)
	Adjusted Geometric Mean + Standard Error	Adjusted Geometric Mean	Adjusted Geometric Mean - Standard Error
Glipizide (GLP) 5 mg	-62.82	-65.18	-67.40
Rosiglitazone (RSG) 4 mg	-80.33	-81.63	-82.84

Repeated Measures Analysis of Percent Change in MMP 9 From Baseline to Month 18

Changes in cardiovascular biomarkers from Baseline to Month 18, such as matrix metalloproteinase-9 (MMP-9). Repeated measures analysis model: Log(value) - log(baseline) = log(baseline) + visit + sex + region + treatment + prior OAD + cardiac procedure + treatment x visit. (NCT00116831)
Timeframe: Baseline to Month 18

Intervention	percent change (Number)
	Adjusted Geometric Mean + Standard Error	Adjusted Geometric Mean	Adjusted Geometric Mean - Standard Error
Glipizide (GLP) 5 mg	-26.5	-30.5	-34.3
Rosiglitazone (RSG) 4 mg	-38.8	-42.2	-45.5

Change in BMI

Change in BMI (body mass index) from study start to 16 weeks (NCT02613897)
Timeframe: Change from baseline to 16 weeks

Intervention	Kg/m^2 (Mean)
DAPA/SAXA (Dapagliflozin Plus Saxagliptin)	-0.8
DAPA (Dapagliflozin Plus Placebo)	-0.66
PCB (Placebo Plus Placebo)	0.16

Change in Body Weight

Change in body weight from baseline to 16 weeks (NCT02613897)
Timeframe: Baseline to 16 weeks

Intervention	Kg (Mean)
DAPA/SAXA (Dapagliflozin Plus Saxagliptin)	-2.28
DAPA (Dapagliflozin Plus Placebo)	-1.76
PCB (Placebo Plus Placebo)	0.26

Change in Fasting Plasma Glucagon (FPG)

A measure of the change in fasting plasma glucagon from study start to 16 weeks (NCT02613897)
Timeframe: Change from baseline to 16 weeks

Intervention	mg/dl (Mean)
DAPA/SAXA (Dapagliflozin Plus Saxagliptin)	-28.52
DAPA (Dapagliflozin Plus Placebo)	26.89
PCB (Placebo Plus Placebo)	6.88

Change in Free Fatty Acids (FFA)

Measure of change in Free Fatty Acids from study start to 16 weeks (NCT02613897)
Timeframe: Change from baseline to 16 weeks

Intervention	mEq/L (Mean)
DAPA/SAXA (Dapagliflozin Plus Saxagliptin)	-0.06
DAPA (Dapagliflozin Plus Placebo)	-0.01
PCB (Placebo Plus Placebo)	0.00

Change in Glucose Oxidation

Change in percentage of glucose oxidation from study start to 16 weeks (NCT02613897)
Timeframe: Change from baseline to 16 weeks

Intervention	percentage of oxidation (Mean)
DAPA/SAXA (Dapagliflozin Plus Saxagliptin)	-22.07
DAPA (Dapagliflozin Plus Placebo)	-46.54
PCB (Placebo Plus Placebo)	4.65

Change in Lipid Oxidation

Change in lipid oxidation percentage from baseline to 16 weeks (NCT02613897)
Timeframe: Change from baseline to 16 weeks

Intervention	percentage of oxidation (Mean)
DAPA/SAXA (Dapagliflozin Plus Saxagliptin)	-11.87
DAPA (Dapagliflozin Plus Placebo)	22.02
PCB (Placebo Plus Placebo)	-6.69

HBA1c

Change in blood glucose level measured over a 3 month period from study start to 16 weeks (NCT02613897)
Timeframe: Change from baseline to 16 weeks

Intervention	percentage change in blood glucose level (Mean)
DAPA/SAXA (Dapagliflozin Plus Saxagliptin)	-1.67
DAPA (Dapagliflozin Plus Placebo)	-1.46
PCB (Placebo Plus Placebo)	0.44

Mean Oral Glucose Tolerance Test (OGTT)

Measure of change in OGTT from study start to 16 weeks (NCT02613897)
Timeframe: Change from baseline to 16 weeks

Intervention	mg/dl (Mean)
DAPA/SAXA (Dapagliflozin Plus Saxagliptin)	-49.62
DAPA (Dapagliflozin Plus Placebo)	-44.24
PCB (Placebo Plus Placebo)	20.26

Change in Endogenous Glucose Production (EGP)

All subjects received a Double-Tracer Oral Glucose Tolerance Test (OGTT) with 75g of glucose containing 14C-glucose together with intravenous primed-continuous infusion of 3(3H)-glucose for 240 minutes, at baseline (prior to) and after 16 weeks of therapy. Blood and urine samples were obtained during the OGTT to determine EGP. (NCT02613897)
Timeframe: Baseline and 16 weeks

Intervention	mg/kg*min (Mean)
	Baseline Measurement	16 weeks
DAPA (Dapagliflozin Plus Placebo)	2.56	2.8
DAPA/SAXA (Dapagliflozin Plus Saxagliptin)	2.45	2.4
PCB (Placebo Plus Placebo)	1.95	2.15

Body Mass Index (BMI)

Body Mass Index (BMI) at 12 months measured as kg/m2 (NCT00432809)
Timeframe: 1 year

Intervention	kg/m2 (Mean)
Medical Therapy	34.4
Gastric Bypass	26.8
Sleeve Gastrectomy	27.2

Body Weight

Body weight in kilograms (kg) measured at 12 months (NCT00432809)
Timeframe: 1 year

Intervention	kg (Mean)
Medical Therapy	99.0
Gastric Bypass	77.3
Sleeve Gastrectomy	75.5

Cardiovascular Medications - Angiotensin-converting Enzyme (ACE Inhibitor) or Angiotensin-receptor Blocker (ARB)

Number of participants taking Angiotensin-converting enzyme (ACE Inhibitor) or Angiotensin-receptor blocker (ARB) at 12 months (NCT00432809)
Timeframe: 1 year

Intervention	participants (Number)
Medical Therapy	26
Gastric Bypass	9
Sleeve Gastrectomy	11

Cardiovascular Medications - Anticoagulants

Number of participants taking anticoagulants at 12 months (NCT00432809)
Timeframe: 1 year

Intervention	participants (Number)
Medical Therapy	24
Gastric Bypass	1
Sleeve Gastrectomy	8

Cardiovascular Medications - Beta Blocker

Number of participants taking Beta Blockers at 12 months (NCT00432809)
Timeframe: 1 year

Intervention	participants (Number)
Medical Therapy	5
Gastric Bypass	9
Sleeve Gastrectomy	3

Cardiovascular Medications - Lipid Lowering Agents

Number of participants taking Lipid lowering agents at 12 months (NCT00432809)
Timeframe: 1 year

Intervention	participants (Number)
Medical Therapy	36
Gastric Bypass	13
Sleeve Gastrectomy	19

Change in Body Mass Index (BMI)

Change in Body Mass Index (BMI) at 12 months, measured in kg/m2 (NCT00432809)
Timeframe: 1 year

Intervention	kg/m2 (Mean)
Medical Therapy	-1.9
Gastric Bypass	-10.2
Sleeve Gastrectomy	-9.0

Change in Body Weight From Baseline

Mean change in body weight from baseline measured in kilograms (kg) (NCT00432809)
Timeframe: 1 year

Intervention	kg (Mean)
Medical Therapy	-5.4
Gastric Bypass	-29.4
Sleeve Gastrectomy	-25.1

Change in Glycated Hemoglobin (HbA1c)

Change in glycated hemoglobin(HbA1c)from baseline in percentage points / percent change (NCT00432809)
Timeframe: 1 year - baseline

Intervention	percentage points of glycated hemoglobin (Mean)
Medical Therapy	-1.4
Gastric Bypass	-2.9
Sleeve Gastrectomy	-2.9

Change in High-density Lipoprotein (HDL)

Percent change in high-density lipoprotein (HDL) at 12 months (NCT00432809)
Timeframe: 1 year

Intervention	mg/dL (Mean)
Medical Therapy	11.3
Gastric Bypass	28.5
Sleeve Gastrectomy	28.4

Change in High-sensitivity C-reactive Protein (Hs-CRP)

Median percent change in high-sensitivity C-reactive protein (hs-CRP)from baseline at 12 months (NCT00432809)
Timeframe: 1 year

Intervention	mg/L (Median)
Medical Therapy	-33.2
Gastric Bypass	-84
Sleeve Gastrectomy	-80

Change in Systolic Blood Pressure (SBP)

Change in Systolic Blood Pressure (SBP) at 12 months (NCT00432809)
Timeframe: 1 year

Intervention	mm Hg (Mean)
Medical Therapy	-3.9
Gastric Bypass	-2.4
Sleeve Gastrectomy	-5.1

Change in Triglycerides

Median percent change in triglycerides at 12 months from baseline measure (NCT00432809)
Timeframe: 1 year

Intervention	mg/dL (Median)
Medical Therapy	-14
Gastric Bypass	-44
Sleeve Gastrectomy	-42

Diabetes Medication - Use of Biguanides

Number of participants taking Biguanides at 12 months (NCT00432809)
Timeframe: 1 year

Intervention	participants (Number)
Medical Therapy	38
Gastric Bypass	10
Sleeve Gastrectomy	19

Diabetes Medication - Use of Incretin Mimetics

Number of participants taking Incretin Mimetics (NCT00432809)
Timeframe: 1 year

Intervention	participants (Number)
Medical Therapy	34
Gastric Bypass	1
Sleeve Gastrectomy	10

Diabetes Medication - Use of Insulin

Number of participants taking insulin at 12 months (NCT00432809)
Timeframe: 1 year

Intervention	participants (Number)
Medical Therapy	15
Gastric Bypass	2
Sleeve Gastrectomy	4

Diabetes Medication - Use of Secretagogue

Number of participants taking Secretagogues at 12 months (NCT00432809)
Timeframe: 1 year

Intervention	participants (Number)
Medical Therapy	10
Gastric Bypass	1
Sleeve Gastrectomy	5

Diabetes Medication - Use of Thiazolidinedione

Number of participants using thiazolidinedione at 12 months (NCT00432809)
Timeframe: 1 year

Intervention	participants (Number)
Medical Therapy	20
Gastric Bypass	0
Sleeve Gastrectomy	5

Fasting Plasma Glucose

Fasting Plasma Glucose measured in mg/dL. (NCT00432809)
Timeframe: 1 year

Intervention	mg/dL (Median)
Medical Therapy	120
Gastric Bypass	99
Sleeve Gastrectomy	97

Glycated Hemoglobin (HbA1c)

Mean glycated hemoglobin (HbA1c) at 12 months for each of the 3 groups, in percentage points (NCT00432809)
Timeframe: 1 year

Intervention	percentage points of glycated hemoglobin (Mean)
Medical Therapy	7.5
Gastric Bypass	6.4
Sleeve Gastrectomy	6.6

Success Rate of Biochemical Resolution of Diabetes at 12 Months as Measured by HbA1c ≤ 6% With no Diabetes Medications

The proportion of subjects with a glycated hemoglobin level of 6% or less(without diabetes medications) 12 months after randomization. (NCT00432809)
Timeframe: 1 year

Intervention	participants (Number)
Medical Therapy	0
Gastric Bypass	21
Sleeve Gastrectomy	13

Success Rate of Biochemical Resolution of Diabetes at 12 Months as Measured by HbA1c ≤ 6%.

The proportion of subjects with a glycated hemoglobin level of 6% or less(with or without diabetes medications) 12 months after randomization (baseline measure). (NCT00432809)
Timeframe: 1 year

Intervention	participants (Number)
Medical Therapy	5
Gastric Bypass	21
Sleeve Gastrectomy	18

Trials

9 trials available for glipizide and Diabetic Angiopathies

Article	Year
Lipid profiling reveals different therapeutic effects of metformin and glipizide in patients with type 2 diabetes and coronary artery disease. Diabetes care, 2014, Volume: 37, Issue:10 Topics: Aged; Blood Glucose; Coronary Artery Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Doub	2014
Assessment on the Prevention of Progression by Rosiglitazone on Atherosclerosis in diabetes patients with Cardiovascular History (APPROACH): study design and baseline characteristics. American heart journal, 2008, Volume: 156, Issue:6 Topics: Adult; Aged; Coronary Artery Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Disease Prog	2008
Evaluation of in-stent restenosis in the APPROACH trial (Assessment on the Prevention of Progression by Rosiglitazone On Atherosclerosis in diabetes patients with Cardiovascular History). The international journal of cardiovascular imaging, 2012, Volume: 28, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Angioplasty, Balloon, Coronary; Coronary Angio	2012
Drug-induced reversal of early diabetic microangiopathy. The New England journal of medicine, 1983, Dec-22, Volume: 309, Issue:25 Topics: Adult; Basement Membrane; Blood Glucose; Capillaries; Diabetic Angiopathies; Female; Glipizide; Gluc	1983
Veterans Affairs Cooperative Study on glycemic control and complications in type II diabetes (VA CSDM). Results of the feasibility trial. Veterans Affairs Cooperative Study in Type II Diabetes. Diabetes care, 1995, Volume: 18, Issue:8 Topics: Aged; Albuminuria; Animals; Biomarkers; Blood Glucose; Blood Glucose Self-Monitoring; Blood Pressure	1995
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131 Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide;	1998
Glycemic control and complications in type II diabetes. Design of a feasibility trial. VA CS Group (CSDM) Diabetes care, 1992, Volume: 15, Issue:11 Topics: Adult; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Electrocardiography; F	1992
Enzyme activities as a predictor of diabetic vasculopathy. The American journal of medicine, 1986, Volume: 80, Issue:4 Topics: Acetylglucosaminidase; Adult; Basement Membrane; Capillaries; Diabetic Angiopathies; Female; Glipizi	1986
Delay of progression of diabetic microangiopathy. Metabolism: clinical and experimental, 1988, Volume: 37, Issue:2 Suppl 1 Topics: Acetylglucosaminidase; Adult; Basement Membrane; Blood Glucose; Diabetic Angiopathies; Glipizide; Gl	1988

Other Studies

6 other studies available for glipizide and Diabetic Angiopathies

Article	Year
Comparative Safety of Sulfonylureas and the Risk of Sudden Cardiac Arrest and Ventricular Arrhythmia. Diabetes care, 2018, Volume: 41, Issue:4 Topics: Aged; Arrhythmias, Cardiac; Cause of Death; Death, Sudden, Cardiac; Diabetic Angiopathies; Female; G	2018
Comparison of mortality and cardiovascular event risk associated with various insulin secretagogues: A nationwide real-world analysis. Diabetes research and clinical practice, 2019, Volume: 152 Topics: Aged; Carbamates; Cardiovascular Diseases; Cohort Studies; Diabetes Mellitus, Type 2; Diabetic Angio	2019
Risk of coronary artery disease associated with initial sulphonylurea treatment of patients with type 2 diabetes: a matched case-control study. Diabetes research and clinical practice, 2008, Volume: 82, Issue:3 Topics: Adult; Case-Control Studies; Coronary Artery Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathi	2008
Glipizide for reversal of early diabetic microangiopathy. The New England journal of medicine, 1984, May-24, Volume: 310, Issue:21 Topics: Blood Glucose; Diabetic Angiopathies; Glipizide; Humans; Sulfonylurea Compounds	1984
The effects of gliclazide and other sulfonylureas on low-density lipoprotein oxidation in vitro. Metabolism: clinical and experimental, 1997, Volume: 46, Issue:12 Suppl 1 Topics: Administration, Oral; Adult; Antioxidants; Ascorbic Acid; Coronary Artery Disease; Diabetes Mellitus	1997
Diabetic microangiopathy in KK mice. VI. Effect of glycemic control on renal glycoprotein metabolism and established glomerulosclerosis. Experimental and molecular pathology, 1990, Volume: 53, Issue:2 Topics: Acetylglucosaminidase; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetic Angiopathie	1990